Prelude Capital Management’s Aclaris Therapeutics ACRS Stock Holding History

Prelude Capital Management’s Portfolio ACRS Stock Details ACRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$18K	Sell
2024 Q4	$264K	Buy
2020 Q3	–	Sell
2020 Q2	$1K	Buy